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Background: Hypoglycemia is the most common complication in insulin treated
diabetes. Though mostly mild, it can be fatal in rare cases: It is hypothesized that
hypoglycemia related QTc prolongation contributes to cardiac arrhythmia.
Objective: To evaluate influence of nocturnal hypoglycemia on QTc and heart rate
variability (HRV) in children with T1D.
Methods: Children and adolescents with T1D for at least 6 months participated in an
observational study using continuous glucose monitoring (CGM) and Holter electro-
cardiogram for five consecutive nights. Mean QTc was calculated for episodes of
nocturnal hypoglycemia (<3.7 mmol/L) and compared to periods of the same duration
preceding hypoglycemia. HRV (RMSSD, low and high frequency power LF and HF)
was analyzed for different 15 min intervals: before hypoglycemia, onset of hypogly-
cemia, before/after nadir, end of hypoglycemia and after hypoglycemia.
Results: Mean QTc during hypoglycemia was significantly longer compared to
euglycemia (412 ± 15 vs. 405 ± 18 ms, p = 0.005). HRV changed significantly:
RMSSD (from 88 ± 57 to 73 ± 43 ms) and HF (from 54 ± 17 to 47 ± 17nu) decreased
from before hypoglycemia to after nadir, while heart rate (from 69 ± 9 to 72
± 12 bpm) and LF (from 44 ± 17 to 52 ± 21 nu) increased (p = 0.04).
Conclusion: A QTc lengthening effect of nocturnal hypoglycemia in children with
T1D was documented. HRV changes occurred even before detection of nocturnal
hypoglycemia by CGM, which may be useful for hypoglycemia prediction.
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1 | INTRODUCTION
Hypoglycemia is an unavoidable and dreaded acute complication of
insulin treated diabetes mellitus. Although most nocturnal hypoglyce-
mic episodes are mild and asymptomatic, they can be fatal in rare
cases: Sudden unexpected death in otherwise healthy young people
with type 1 diabetes (T1D) has been reported to be up to 10 times
higher compared to a population without diabetes.1,2 It is hypothe-
sized that these overnight deaths (so called “dead in bed phenome-
non”) are induced by hypoglycemia.3,4 The precise mechanism by
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which hypoglycemia leads to death is still not fully understood. There
is some evidence that insulin-induced hypokalemia in combination
with sympatho-adrenergic stimulation leads to fatal cardiac ventricular
arrhythmia in adults.5
Even episodes of mild or moderate hypoglycemia seem to have
an impact on cardiac repolarization: In adults with6–9 and without
diabetes5,10 lengthening of QTc intervals during experimental and
spontaneous hypoglycemia has been documented.
In a previous study, we observed frequent nocturnal hypoglyce-
mia in children with T1D, often prolonged for hours.11 Hence, the
question remains, whether alterations of QTc intervals occur during
nocturnal hypoglycemia in children with diabetes.
Besides QTc intervals, cardiac regulation is represented by
heart rate variability. Heart rate variability measures the beat-to-
beat fluctuation of heart rate and represents the interplay of the
sympathetic and parasympathetic nervous system.12 Because
hypoglycemia stimulates the sympathetic nervous system, a reac-
tion of heart rate variability during episodes of hypoglycemia can
be assumed. In adults, such hypoglycemia-induced changes in
heart rate variability have already been reported.7,9,13 It is
hypothesized that these changes may be helpful in the prediction
of hypoglycemia.13,14 However, in children with T1D, the effect
of hypoglycemia on heart rate variability has not been studied
so far.
Therefore, aims of this study were to investigate if nocturnal
hypoglycemia results in QTc prolongation and changes in heart rate
variability in children with T1D.
2 | RESEARCH DESIGN AND METHODS
2.1 | Participants
Children and adolescents aged below 18 years with T1D for at least
6 months and followed at our outpatient department were recruited.
Participants with pre-existing cardiac disease or medication known to
affect cardiac function were excluded. Participants aged 14 years and
older and all parents of the participants were asked to provide written
informed consent.
The study was approved by the local ethics committee (BASEC
2016-01772).
2.2 | Study design
We performed a prospective observational study in children with T1D
in the home setting.
After assessment of baseline data (HbA1c, weight, height, age,
diabetes duration, insulin treatment/dosage) participants under-
went a 5-day monitoring period: Blinded continuous glucose mon-
itoring (CGM) was performed during five consecutive days and
nights and combined with Holter electrocardiogram (ECG) record-
ing during every night. Participants continued with their routine
insulin treatment and daily activities and were instructed to per-
form at least three capillary blood glucose measurements per day
for calibration and to record injected insulin doses, consumed car-
bohydrates, bed- and wake-up time and hypoglycemic symptoms
in a logbook. After 5 days, the devices were returned for data
download.
2.3 | Baseline assessments
HbA1c, weight, height, insulin treatment and insulin dose (units/kg/day
and percentage of basal insulin) were documented at the routine visit
preceding the study. All participants were seen by a cardiologist and car-
diac disease (such as congenital or acquired structural heart disease,
heart insufficiency or clinically relevant arrhythmia) was excluded. At the
start of the measurement period, a capillary blood sample was taken for
the analysis of serum calcium, potassium and magnesium.
2.4 | Continuous glucose monitoring
Glucose was measured by a blinded CGM system (iPro Transmitter and
Enlite sensor, Medtronic Minimed, Northridge, CA). The system has proven
accuracy in children with a mean absolute relative difference (MARD) of
10.1%, and in the range of 2.22–4.44 mmol/L a sensor-to blood glucose
agreement of 85.5% has been reported.15 If participants were already using
a CGMsystem (DexcomorMedtronic), CGMdata from these deviceswere
used for analysis. The performance of theDexcomG4 sensor is comparable
to the Enlite sensor (MARD11%, accuracy in hypoglycemia 80%).16,17
2.5 | Electrocardiogram
A three channel Holter ECG (Schiller, FD12plus) was mounted by the
participants and parents every evening and worn at nighttime (from
bed time to wake up time) for at least five consecutive nights. The
participants/their families were educated on the use of the Holter
ECG and written and illustrated instructions were handed out.
2.6 | CGM analysis
Hypoglycemia was defined as interstitial glucose below 3.7 mmol/L
for at least 15 min. A hypoglycemic event was considered symptom-
atic, if hypoglycemic symptoms were documented in the logbook.
2.7 | ECG analysis
All ECG recordings were screened by a cardiologist and artifacts were
excluded. Excluded beats were not replaced by interpolated beats.
ECGs were transferred to MATLAB (MathWorks, Natick, MA) and
Labchart (Version 8, AD Instruments, Sidney, AU) for further analysis.
1024 BACHMANN ET AL.
QTc was calculated by the Bazett formula (QT divided by the square
root of the RR interval). For every episode of hypoglycemia, mean QTc of
the entire episode was calculated and compared to a preceding interval of
the same duration. To evaluate the effect of sensor glucose on QTc inter-
vals, all recorded sensor glucose values were correlated to the
correspondingQTc intervals (5 minmeans). To consider a possible time del-
ayed effect of glucose onQTc, glucose level with time shiftedQTc intervals
(from15 to 225 min)were compared.
2.8 | Heart rate variability
After exclusion of artifacts, RR intervals were identified automatically
by the LabChart software, and heart rate variability parameters
according to standards18 were calculated.
Time domain analysis included standard deviation of the RR inter-
val (SDRR) and square root of the mean standard differences of suc-
cessive RR intervals (RMSSD). SDRR represents the overall variability
and cannot be assigned to a specific part of the autonomous nervous
system, whereas RMSSD indicates short-term variability and repre-
sents parasympathetic activity.
Frequency domain analysis was performed by fast Fourier trans-
formation to analyze the parameters low frequency power (LF, 0.04–
0.15 Hz) and high frequency power (HF, 0.15–0.4 Hz). HF reflects
parasympathetic activity, whereas LF is considered to be a marker of
sympathetic modulation.
Heart rate variability (HRV) parameters were calculated in 15 min
windows before the onset of hypoglycemia, at the start of hypoglyce-
mia, before nadir, after nadir, at the end of hypoglycemia and for the
first 15 min after a hypoglycemic episode.
2.9 | Statistical analysis
Baseline data and hypoglycemic episodes were described using fre-
quencies (%), means (±SD) or medians (range) as appropriate. Differ-
ences between average QTc intervals before and during hypoglycemic
episodes were compared by random-intercepts regression analysis
(using patient as a random variable). Possible moderation by variables
such as sex, age, diabetes duration, HbA1c, duration and nadir of
hypoglycemia and serum level of calcium, potassium and magnesium
was examined by testing interaction effects between the candidate
moderator and the episode (hypoglycemic episode yes/no).
To estimate the effect of glucose values on concurrent and subse-
quent QT intervals, we employed the same analysis method (i.e., random-
intercepts regression analysis with patient as a random variable).
Heart rate variability parameters over time were estimated by
random-intercepts regression analysis, using episodes as random vari-
able. For each parameter, two separate models were tested: a first
from before hypoglycemia to after nadir; and a second from before
nadir to after hypoglycemia. Analyses were performed using SAS 9.4
(SAS Institute, Cary, NC).
3 | RESULTS
3.1 | Participant characteristics
Twenty-five children (44% female) aged 8.1–17.6 years (mean age
13.5 years, SD 2.5 years) were included in the study. Diabetes dura-
tion ranged from 0.5 to 13.3 years. Fourteen participants (56%) used
continuous subcutaneous insulin infusion, HbA1c ranged from 6.3 to
12.9% (mean 7.8%, SD 1.4%).
See Table 1 for an overview of baseline characteristics.
3.2 | Recordings
Complete simultaneous CGM and Holter ECG recordings for five
nights were available in 13 patients (=65 nights), 4 complete nights in
another 8 patients (=32 nights). In four children, more than one night
of glucose or ECG was missing. A total of 106 nights with complete
simultaneous recordings were available for analyses. Twelve partici-
pants used their own CGM (10 Medtronic, 2 Dexcom), 13 used the
iPro system.
3.3 | Hypoglycemia
During 32 nights 42 episodes of nocturnal hypoglycemia occurred in
19 patients. Fourteen patients had repeated nocturnal hypoglycemia.
Simultaneous ECG recordings were available for 34 hypoglycemic epi-
sodes in 17 patients, in 11 patients two or more episode were inte-
grated in the analysis. In 16 (47%) of those episodes nadir sensor
glucose level was below 3.0 mmol/L, in 18 episodes between 3.0 and
3.6 mmol/L.
The duration of analyzed hypoglycemia events ranged from 15 to
365 min (mean 101 min, SD 78 min). Only five events of nocturnal
hypoglycemia (all with ECG recording) were stated as symptomatic
(sweating, trembling).
TABLE 1 Baseline and laboratory participant characteristics
Mean (SD) Median (range)
N = 25
Age, years 13.5 (2.5) 13.9 (8.1–17.6)
Male, n/% 14/56%
HbA1c, % 7.8 (1.4) 7.5 (6.3–12.9)
HbA1c, mmol/mmol 62.1 (14.8) 58.5 (45.4–117.5)
Insulin regimen: CSII, n/% 14/56%
Insulin, U/kg/d 0.9 (0.2) 0.9 (0.5–1.4)
Pre-study potassium, mmol/l 4.7 (0.5) 4.6 (3.8–5.9)
Pre-study calcium, mmol/l 2.4 (0.1) 2.4 (2.2–2.6)
Pre-study magnesium, mmol/l 0.8 (0.05) 0.8 (0.7–0.9)
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3.4 | Arrhythmia
No cardiac arrhythmias were observed.
3.5 | Cardiac repolarization/QTc
3.5.1 | QTcintervals and nocturnal hypoglycemia
Mean QTc during nocturnal hypoglycemia (412 ± 15 ms) was longer
compared to euglycemia (405 ± 18 ms, p = 0.005), Figure 1. This
change was not dependent on age (p = 0.99), sex (p = 0.06), HbA1c
(p = 0.76) or duration of diabetes disease (p = 0.31). No significant
impact on QTc lengthening was observed for the duration or severity
(nadir) of the hypoglycemic episode (p = 0.90 and 0.38, respectively).
However, QTc prolongation was more pronounced with lower magne-
sium levels (p = 0.045).
3.5.2 | Overall correlation of QTc intervals and
glucose levels
QTc duration and interstitial glucose were inversely correlated: QTc inter-
vals were longer with lower glucose levels (p-values between <0.001 and
0.02 depending on lag times; Figure 2). This effect was not observed when
QTc intervals were correlated to simultaneously recorded glucose values,
but only detectable from a time delay of 15 min on. The strongest effect
of glucose level on QTc intervals was seen after 105 min: per every
1 mmol/L fall in glucose, QTc increased by 0.96 ms (p = <0.001,
Figure S1), after which the association faded again.
3.6 | Heart rate variability
Changes in heart rate and HRV parameters are displayed in Table 2
and Figure 3.
Heart rate increased from the 15 min interval before hypoglyce-
mia (mean 69 ± 9 bpm) to the 15 min interval after nadir (mean 72
± 12 bpm, p = 0.040, Figure 3A).
Similarly, several HRV parameters changed during hypoglycemia,
that is, from 15 min before hypoglycemia to the interval after nadir of
the hypoglycemic event. RMSSD decreased from 88 ± 57 ms to 73
± 43 ms (p = 0.039, Figure 3B), as well as HF power (given in normal-
ized units): from 54 ± 17 to 47 ± 19 (p = 0.041, Figure 3D).
F IGURE 1 QTc(s) during hypoglycemic episodes, compared to
preceding intervals of the same duration (thick gray line represents
mean, black bars represent ±1 SD)
F IGURE 2 Associations of QTc and
interstitial glucose for different lag times,
from concurrently measured (0 min) to
glucose preceding QTc (up to 225 min).
Bars represent the increase in QTc
(ms) for each 1 mmol/L decrease in
glucose. *p < 0.05, **p < 0.01,
***p < 0.001
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Heart rate, bpm 69 (9) 68 (8) 69 (10) 72 (12) 0.040 73 (12) 69 (17) 0.112
RMSSD, ms 88 (57) 80 (45) 79 (42) 73 (43) 0.040 77 (47) 85 (45) 0.080
SDRR, ms 97 (39) 98 (36) 95 (32) 99 (33) 0.99 102 (34) 99 (39) 0.768
pRR50, % 38 (23) 38 (21) 38 (21) 33 (23) 0.14 33 (22) 37 (21) 0.184
LF, nu 44 (17) 48 (19) 48 (18) 52 (21) 0.048 51 (20) 48 (14) 0.394
HF, nu 54 (17) 50 (17) 51 (17) 47 (19) 0.041 47 (17) 49 (14) 0.538
LF/HF 1.0 (0.7) 1.2 (0.8) 1.2 (0.7) 1.6 (1.3) 0.024 1.5 (1.3) 1.2 (0.7) 0.116
Total, ms2 4150 (3163) 2930 (1854) 3359 (2487) 4572 (2765) 0.17 4896 (8980) 3720 (2488) 0.182
Note: Parameters calculated for different intervals of 15 min. Values given in mean and SD.
Abbreviations: HF, high frequency power, given in normalized units; HRV, heart rate variability; LF, low frequency power, given in normalized units;
pRR50, percentage of subsequent RR intervals that differ more than 50 ms; RMSSD, square root of the mean standard differences of successive RR
intervals; SDRR, standard deviation of the RR interval.
aRepresents linearly tested change from before hypoglycemia to after nadir.
bRepresents linearly tested change from after nadir to after hypoglycemia.
F IGURE 3 Changes of heart rate and
HRV during hypoglycemia. (A) Heart rate
(bpm). (B) RMSSD (ms; square root of the
mean standard differences of successive
RR Intervals) (C) LF (normalized units, nu),
low frequency power. (D) HF (nu) high
frequency power. HR and LF increase
from before hypoglycemia to after nadir
with no further change thereafter.
RMSSD and HF decrease in the same
time intervals. HF, high frequency power;
HRV, heart rate variability; LF, low
frequency power
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LF power (given in normalized units) increased from 44 ± 17 to
52 ± 21 (p = 0.048 s. Figure 3C), as did the relation LF/HF (from
1.0 ± 0.7 to 1.6 ± 1.3, p = 0.024).
These changes in HRV variables were not dependent on age,
sex, HbA1c, diabetes duration, the duration or nadir of
hypoglycemia.
No significant changes in the intervals after nadir to end of hypo-
glycemia and after hypoglycemia were observed. Furthermore, no sig-
nificant changes during hypoglycemia were observed for SDRR,
pRR50 or total power.
4 | DISCUSSION
This study shows that nocturnal hypoglycemia causes mild but signifi-
cant prolongation of corrected QT intervals in children with T1D, and
that QTc intervals correlate directly with glucose levels most pro-
nounced toward the end of the hypoglycemic episode. Furthermore,
HRV parameters changed significantly during hypoglycemia reflecting
autonomic modulation. To our knowledge, this is the first study that
evaluates cardiac repolarization and heart rate variability during epi-
sodes of spontaneous nocturnal hypoglycemia in children with T1D in
the home setting.
The prolongation of QTc intervals was significant, however, no
abnormal QTc values (i.e., longer than 460 ms) were seen. The
changes in QTc intervals seen in our study were rather small. This
could be associated to the fact that ECG was only measured through
the night. It is known, that sympatho-adrenergic response is reduced
by sleep and horizontal position.19
The extent of QTc lengthening in our study is comparable to an
earlier study in children with diabetes,20 where glucose was measured
in serial venous and not CGM overnight samplings.
Several studies in adults reported a lengthening of QTc intervals
during spontaneous nocturnal hypoglycemia, however with variable
extent and different methods,6,8,9 Table S1.
A recent study differentiating between hypoglycemia at daytime and
nighttime in 37 adults with diabetes mellitus showed a moderate change
in QTc interval during the day and an even smaller change at nighttime.9
Gill et al used a setting comparable to our study and found a more
distinct prolongation of QTc during hypoglycemia compared to
euglycemia in 25 adults with type 1 diabetes.8
One single study group documented even shorter QTc intervals
during nocturnal hypoglycemia compared to euglycemia.21 This study
however, included only 10 hypoglycemic episodes in six adult
patients, and they chose a very short period of 10 heartbeats around
the nadir of hypoglycemia for QTc analysis.
The QTc lengthening in our patients was neither dependent of
the duration nor the severity of the hypoglycemic episode. This may
be explained by the small number of hypoglycemic episodes that were
available with concomitant ECG recording.
Because changes in cardiac repolarization are induced by
sympatho-adrenergic stimulation due to hypoglycemia, we could have
expected a smaller change in QTc in children with longer diabetes
duration or history of severe hypoglycemia. However, this was not
observed, which could be attributed to the rather short disease dura-
tion in children and the small number of participants that experienced
severe hypoglycemia in the past. The only moderating factor that
influenced QTc prolongation in the context of hypoglycemia was the
serum magnesium level. In participants with lower magnesium levels,
the increase in QTc was more pronounced. This is of relevance, as
serum magnesium levels are easy to measure and substitution is
uncomplicated, not expensive and with few side effects. The effect of
magnesium on the hypoglycemia induced QTc lengthening is even
more significant given that children with type 1 diabetes were found
to have lower magnesium levels than healthy controls.22
In addition to a lengthening of QTc intervals during nocturnal
hypoglycemia in children, QTc intervals were correlated to glucose
levels. The strongest effect could be seen with a delay of 105 min.
This temporal association could support the hypothesis that hypo-
glycemia counter regulation by sympatho-adrenergic activation is
responsible for the QTc lengthening. Further inpatient studies
with the possibility to measure adrenal hormones and ECG during
nocturnal hypoglycemia would be necessary to prove this
hypothesis.
Furthermore, the study found significant changes in HRV parame-
ters reflecting autonomic modulation during hypoglycemia.
Of note, a significant change in HRV parameters occurred already
15 min before low sensor glucose levels were detected. This is in
accordance with results of a study in adults with diabetes that com-
bined HRV measures from Holter ECGs with CGM and showed that
hypoglycemia could be predicted earlier and with a higher sensitivity
than by CGM alone.14,23 Two other studies in adults report hypogly-
cemia induced changes in HRV parameters.9,24 In contrast to our
results, they reported lower values for LF in hypoglycemia. However,
their approach was not comparable to our study: HRV changes were
not analyzed before the onset and throughout hypoglycemia, but they
compared a 5 min period in hypoglycemia with an euglycemic period
in another night.
A recent publication presented data of HRV changes (LF/HF and
RMSSD) before the onset of hypoglycemia measured by a Health-
Patch in 23 adults. Similar to our study, LF/HF increased significantly,
whereas RMSSD decreased.13
So far, HRV during nocturnal hypoglycemia has not been studied
in children. However, one recent study reported a change in heart rate
before nocturnal hypoglycemia compared to euglycemia.25
Strengths of this study are the continuous recording of high-
quality long-term ECG, the gold standard for HRV analysis combined
with glucose monitoring for five consecutive nights. A second
strength is the real-life setting of the study. Furthermore, young
patients from school age were included.
Limitations are the small sample size of 25 participants. However,
other studies in this field report data of a similar sample size. As the
study was performed in the home setting, and ECG recording was ini-
tiated by the participants/parents every night, technical problems
occurred in some participants resulting in incomplete recordings. Con-
firmation of low sensor glucose levels by capillary blood glucose
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measurements would have been desirable. However, we mostly used
blinded CGM and only analyzed nighttime glucose profiles, thus hypo-
glycemia was not noticed by the patients in most cases. As the mea-
surements were not carried out in the hospital, Magnesium levels
could not be measured at the moment of hypoglycemia, but at the
first day, before the start of the measurement period. Therefore, some
variations in Magnesium levels during the study cannot be ruled out.
However, a rather low intraindividual variation in serum Magnesium
levels has been reported in different studies (1.93 and 3.2%).26,27
In conclusion, this study documents that nocturnal hypoglycemia
has a QTc prolonging effect in children with diabetes. This QTc alter-
ation was not clinically relevant in our patient group. However, one can
assume that in predisposed subjects (i.e., intrinsic QT prolongation due
to genetic polymorphisms in ion channel genes, electrolyte imbalances
and/or co-medications which prolong QT intervals), QTc prolongation
aggravated due to hypoglycemia might become clinically significant.
Such patients should be identified and risk constellations avoided.
This is particularly important, as there is evidence, that children
with T1D have longer QTc intervals than healthy controls.28–30 A
recent study even found prolonged QTc intervals (>450 ms) in one-
third of children with T1D.25 A superimposed additional QTc
prolonging effect of hypoglycemia could be critical in those children.
Remarkably, not only hypoglycemia but also diabetic ketoacidosis
(DKA) seems to have an impact on QTc intervals: several studies
report mean QTc intervals during DKA between 447 and 458 ms with
prolonged QTc in 31 up to 53% of patients.31–34
It may therefore be advisable to perform occasional ECG recordings
in children with diabetes, as treatment with beta-blockers could reduce
the risk of cardiac arrhythmia.35 In these patients at risk, hypoglycemia
should be avoided even more aggressively. Avoidance of hypoglycemia
is however more difficult in children, because they may not be able to
recognize or communicate symptoms of hypoglycemia due to their
age.36 In addition, eating behavior and physical activity are mostly
unforeseeable. Children with T1D would therefore particularly benefit
from the possibility to earlier detect hypoglycemic events.
The findings of this study suggest that HRV measurements could
help to detect hypoglycemia in advance. We could show for the first
time in children that HRV parameters change during hypoglycemia
and even before hypoglycemia was detected by CGM. Larger studies
would be needed to further evaluate the association of HRV and glu-
cose and to confirm these findings.
The recording by Holter ECG used in this study would not be suit-
able for everyday use and was only performed at nighttime. Comfort-
able wearable devices measuring heart rate variability are however
available, and it may thereby be promising to include measurements
of HRV into treatment algorithms for children with diabetes.
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